CARDAX PHARMA
Cardax Pharmaceuticals develops proprietary small molecule therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles—including dyslipidemia, metabolic disease, arthritis, cardiovascular disease, hepatitis, macular degeneration, and many others. Most anti-inflammatory drugs have significant safety and side effect issues that limit their utility. In contrast, the company’s proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers robust efficacy combined with exceptional safety, oral bioavailability, and tissue selectivity.
CARDAX PHARMA
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Honolulu, Hawaii, United States
Country:
United States
Website Url:
http://www.cardaxpharma.com
Total Employee:
1+
Status:
Active
Contact:
(808) 457-1400
Email Addresses:
[email protected]
Total Funding:
8.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Advantage Capital
Advantage Capital investment in Venture Round - Cardax Pharma
Official Site Inspections
http://www.cardaxpharma.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cardax Pharma"
About Us – Cardax, Inc. | CDXI - cardaxpharma.com
Cardax, Inc. (CDXI)
Mar 31, 2021 Cardax is a consumer health company focused on marketing ZanthoSyn ®, a physician recommended astaxanthin dietary supplement for inflammatory health.* Cardax previously focused on development of …See details»
Contact Us – Cardax, Inc. | CDXI - cardaxpharma.com
Corporate Offices 2800 Woodlawn Drive, Suite 129 Honolulu, Hawaii 96822 Phone: (808) 457-1400 Fax: (808) 237-5901 E-Mail Inquiries General: [email protected] Investors: …See details»
Management Team :: Cardax, Inc. (CDXI) - ir.cardaxpharma.com
David M. Watumull COO and CFO With two decades of experience in the life sciences industry, David M. Watumull has extensive business experience, having served as Chief Operating …See details»
Cardax, Inc. - LinkedIn
Cardax, Inc. Pharmaceutical Manufacturing Honolulu, HI - Hawaii 713 followers Cardax is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet …See details»
Instrument Name Cardax Inc Instrument Symbol (CDXI) - The …
See the company profile for Cardax Inc (CDXI) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Cardax Company Profile | Management and Employees List
Find contact information for Cardax. Learn about their Research & Development, Business Services market share, competitors, and Cardax's email format.See details»
Profile :: Cardax, Inc. (CDXI) - ir.cardaxpharma.com
Business Description Cardax is a consumer health company focused on marketing ZanthoSyn ®, a physician recommended astaxanthin dietary supplement for inflammatory health.* Cardax …See details»
Cardax - VentureRadar
"Cardax is a development stage biopharmaceutical company primarily focused on the development of pharmaceuticals for chronic diseases driven by inflammation. CDX-101, our …See details»
Cardax Pharma - Crunchbase Company Profile & Funding
Cardax Pharma offers small molecule therapies for unmet medical needs such as hepatitis, arthritis, cardiovascular diseases, and more.See details»
CORPORATE PRESENTATION - cardaxpharma.com
Unless otherwise indicated, information contained in this presentation concerning our company, our business, the services we provide and intend to provide, our industry and our general …See details»
Cardax Company Profile - Office Locations, Competitors, Revenue ...
Oct 29, 2024 Cardax has 3 employees at their 1 location and $710.95 k in annual revenue in FY 2019. See insights on Cardax including office locations, competitors, revenue, financials, …See details»
FAQ - Cardax, Inc.
May 5, 2006 What is Cardax, Inc.'s stock symbol? Our common stock is currently quoted on the OTCQB, but following our voluntary suspension of Exchange Act reporting in August 2021, we …See details»
CARDAX PHARMA, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CARDAX PHARMA, INC. of Honolulu, HI. Get the latest business insights from Dun & Bradstreet.See details»
Company History – Cardax, Inc. | CDXI
May 5, 2006 Cardax is a development stage biopharmaceutical company primarily focused on the development of pharmaceuticals for chronic diseases driven by inflammation.See details»
Cardax Reports 2020 Results - Cardax, Inc. (CDXI)
Apr 15, 2021 Cardax Reports 2020 Results Download as PDF April 15, 2021 PDF HTML ZIP XLS HTML - Net loss and operating expenses decreased vs. 2019 - ZanthoSyn® revenues …See details»
Programs – Cardax, Inc. | CDXI - cardaxpharma.com
Recent News Cardax Announces Breakthrough Longevity Results with ZanthoSyn® in NIH-Funded Study December 6, 2023 Cardax Refocuses on ZanthoSyn® Consumer Health …See details»
Newsroom – Cardax, Inc. | CDXI - cardaxpharma.com
May 14, 2021 David G. Watumull, CEO of Cardax, was on Hawaii News Now Sunrise to discuss Cardax's new clinical trial studying the effects of astaxanthin on cardio-inflammatory health.See details»
Press Releases - Cardax, Inc.
Apr 15, 2021 Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus DiseaseSee details»